Given that only about 1 in 4 eligible individuals currently receive housing assistance, a potential benefit of extending housing assistance may be earlier-stage diagnoses of these cancers,” ...

Thrombosis occurs in more than 1 in 10 adults receiving PEGylated asparaginase (Asp)–based therapy for acute lymphoblastic leukemia (ALL), with a 4-fold ...

Disitamab vedotin plus toripalimab improved progression-free survival and overall survival when compared to chemotherapy.

Consistently reaching guidelines at moderate levels over three decades associated with significant reduction in DSC risk.

Sevabertinib produced “robust and durable” responses in patients with HER2-mutant NSCLC, whether they were previously treated or untreated in the advanced setting, according to Xiuning Le, MD, PhD.

CRT consisted of concomitant cisplatin (3 doses of 100 mg/m 2 every 3 weeks or 7 doses of 40 mg/m 2 every week) and radiotherapy (70 Gy in 35 fractions). A single dose of durvalumab (1500 mg) was ...